XENON PHARMACEUTICALS INC. (XENE) /
The revenue of XENON PHARMACEUTICALS INC. over the past 10 years
Chart XENON PHARMACEUTICALS INC.: revenue, fiscal 2016–2025 Open the chart →XENON PHARMACEUTICALS INC. reported revenue of $7.5M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.8M — up 316% over 9 years. Year over year, revenue rose twice and fell 4 times. In these years the highest was $32.17M in fiscal 2020; the lowest $0 in fiscal 2023. The largest one-year move was in fiscal 2020: up 371%, from $6.83M to $32.17M. No revenue figure is on file for fiscal 2018.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $7.5M |
| 2024ended Dec 31, 2024 | $0 |
| 2023ended Dec 31, 2023 | $0 |
| 2022ended Dec 31, 2022 | $9.43M |
| 2021ended Dec 31, 2021 | $18.44M |
| 2020ended Dec 31, 2020 | $32.17M |
| 2019ended Dec 31, 2019 | $6.83M |
| 2018ended Dec 31, 2018 | — |
| 2017ended Dec 31, 2017 | $311K |
| 2016ended Dec 31, 2016 | $1.8M |
Fiscal years as XENON PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XENON PHARMACEUTICALS INC.
- The profitability of XENON PHARMACEUTICALS INC.
- The cash flow of XENON PHARMACEUTICALS INC.
- The debt of XENON PHARMACEUTICALS INC.
- All of XENON PHARMACEUTICALS INC.'s financials, charted
Companies of a similar size
- BOOTBoot Barn Holdings, Inc.
- SMGScotts Miracle-Gro Co
- IRTINDEPENDENCE REALTY TRUST, INC.
- PRIMPrimoris Services Corporation
- BATRAATLANTA BRAVES HOLDINGS, INC.
Not investment advice. This page shows what XENON PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.